RSV Season Warning: What to Know Before It Peaks

RSV doesn't get the same attention as flu or COVID, and that's part of the problem. It circulates quietly every year, usually gets written off as "just a cold," and then quietly fills pediatric wards and geriatric units once winter sets in. In India, RSV cases generally rise between October and February, tracking with cooler, drier weather that helps the virus survive longer and spreads more easily as people spend more time indoors.

Most healthy adults who catch RSV will have a rough week and move on. The real concern sits at the two ends of the age spectrum: infants under one, and adults over 65, especially those with existing heart or lung conditions. Hospital data consistently shows emergency visits and hospitalizations concentrated among children under four, even in seasons where the virus behaves unpredictably.

In clinical practice, this is often missed because RSV looks identical to a common cold for the first two or three days. Parents don't panic over a runny nose and mild cough, and they shouldn't have to. But that early resemblance is exactly why warning signs matter more than the initial symptoms.

What's Actually Changed in RSV Prevention

Here's the part that's genuinely different from five years ago: prevention options now exist that simply didn't before. The first long-acting monoclonal antibody product to protect infants through their first RSV season was authorized in 2022, and a maternal RSV vaccine followed in 2023, designed to pass protection to newborns through pregnancy. That's a real shift, not a marketing claim. Before this, there was no direct way to protect infants against RSV beyond general hygiene.

For older adults, RSV vaccines are now part of the same conversation as flu shots and pneumonia vaccines, particularly for those with chronic heart or lung disease. Not everyone in this age group necessarily needs one, and eligibility depends on individual health history, so this is a conversation for a doctor's office, not a pharmacy counter decision.

Worth being honest here too: none of these tools eliminate RSV risk entirely. They reduce the odds of severe illness and hospitalization. That's a meaningful difference, but it's not the same as immunity.

Symptoms Worth Tracking, Not Panicking Over

RSV usually starts exactly like a cold: runny nose, mild cough, low-grade fever, maybe a bit of fussiness in children. That's the stage most people manage at home with rest and fluids, and reasonably so.

The signs that change the picture are specific. In infants, that includes rapid or labored breathing, visible chest retractions with each breath, a bluish tint around the lips, unusual lethargy, or a noticeable drop in wet diapers. In older adults, watch for worsening shortness of breath, confusion, chest tightness, or oxygen levels that don't recover with rest. None of these are subtle once you know to look for them, but they're easy to miss if you're expecting "just a cold."

When to Actually See a Doctor

If symptoms are mild and the person is otherwise healthy, home care and monitoring is usually reasonable. That's not being dismissive; it's how RSV plays out for most people most of the time.

The moment breathing becomes visibly effortful, feeding drops off in an infant, or an older adult's baseline confusion or breathlessness worsens, that's when a same-day visit to a general physician or pediatrician makes sense. If breathing distress is severe, this becomes an emergency situation, not a wait-and-see one.